Equity Brief · Healthcare2026-05-20
SYK·Healthcare

Stryker Corporation

I · Analiza AI

Pe scurt

Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].

Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].

Stryker is financially robust with excellent margins, strong cash generation, and low leverage.

Pe scurt AI analysisÎncredere 8/10

Scor Sentinellis

10/10

Financially healthy

Capitalizare bursieră

$121.8B

Venituri (12 luni)

$25.1B

II · Știri recente

Ce a mișcat prețul

5 stories · ranked by relevance

  • macro2026-05-18

    PAHC or SYK: Which Is the Better Value Stock Right Now?

    Yahoo Finance

  • macro2026-05-19

    BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem

    Yahoo Finance

  • macro2026-05-16

    Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback

    Simply Wall St

  • macro2026-05-15

    Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

    Yahoo Finance

  • macro2026-05-15

    Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

    Yahoo Finance

Premium · gratuit cu orice cont

Stryker trades at a PE ratio of 36.8x, which is elevated relative to historical norms and leaves the stock vulnerable to significant correction if earnings disappoint, especially with the next earnings report due July 30, 2026 [Yahoo Finance] [EODHD]

1 din 4 riscuri din acest raport

Riscuri

4

Oportunități

6

Semnale de alarmă

2

Conducere

10

Încă 21 de constatări în raportul complet — gratuit cu orice cont.

Deblochează analiza completă Stryker Corporation

Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.

  • 4 riscuri, 6 oportunități și 2 semnale de alarmă — fiecare cu sursa lui
  • Peste 100 de indicatori financiari, cu grafice și comparații
  • Rezumate complete ale știrilor, cu linkuri către surse
  • Echipa de conducere și remunerația
  • Export PDF pentru citit offline
Deblochează 12 constatări3 rapoarte gratuite · fără card

III · Companii similare

Ai putea citi și

Same sector · Healthcare or comparable health

Vrei compania asta pe lista ta?

Read three companies free. Fără card.

Primești 3 rapoarte gratuite